Taiwan Clinical Trials ─ Origin

  With the rapid development of international biotechnology industry, various types of research and development have been advanced to the clinical trial stage. Taiwan has invested considerable energy in clinical trials for decades, but in recent years, it has faced intense area competition. In particular, Japan and South Korea have put much effort in multi-regional clinical trials, which have caused Taiwan to face this severe competitive situation. To this end, there is a strong demand for Taiwan to set up a one-stop shop to provide domestic and international partners with key information on Taiwan’s clinical trial environment. "Taiwan Clinical Trials" emerged in 2014 as the times require. With the support of the Ministry of Health and Welfare Taiwan, Taiwan Clinical Trials is established and managed by the Center for Drug Evaluation.

  The quality, characteristics, capability, and past achievements of Taiwan's clinical trials is shown to the world through this website. With a user-friendly interface, it can greatly optimize the understanding of current clinical trial capacity in Taiwan, and facilitate clinical trial conduction, drug R&D investment in Taiwan. Meanwhile, through this website, the public can correctly understand the value and importance of clinical trials.